Transition From Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Impact On Glycemic Parameters

被引：0
|
作者：
Diekmann, F. [1 ]
Tedesco-Silva, H. [2 ]
Peddi, V. [3 ]
Sanchez-Fructoso, A. [4 ]
Marder, B. [5 ]
Russ, G. [6 ]
Flynn, A. [7 ]
Hahn, C. [7 ]
Li, H. [7 ]
Tortorici, M. [7 ]
Schulman, S. [7 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Rim & Hipertensao, Sao Paulo, Brazil
[3] Calif Pacific Med Ctr, San Francisco, CA USA
[4] Hosp Clin San Carlos, Madrid, Spain
[5] Presbyterian St Lukes Med Ctr, Denver, CO USA
[6] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[7] Pfizer, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B969
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [31] The Value of Chronic Renal Allograft Injury Score for the Conversion from Cycspoline to Tacrolimus or Sirolimus in Chronic Allograft Nephropathy
    Wen, Jiqiu
    Li, Leishi
    Chen, Jisong
    Ji, Shuming
    Chen, Huiping
    Sun, Qiquan
    Cheng, Dongrui
    Liu, Zhihong
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 31 - 31
  • [32] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [33] Conversion From Tacrolimus/Mycophenolic Acid to Tacrolimus/Leflunomide to Treat Cutaneous Warts in a Series of Four Pediatric Renal Allograft Recipients
    Lieuko Nguyen
    McClellan, Robert B.
    Chaudhuri, Abanti
    Alexander, Steven R.
    Chen, Sharon F.
    Concepcion, Waldo
    Grimm, Paul
    TRANSPLANTATION, 2012, 94 (05) : 450 - 455
  • [34] Response to "Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients"
    Thervet, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 597 - 597
  • [35] Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients
    Beaudreuil, S.
    Becquemont, L.
    Schermann, J. M.
    Verstuyft, C.
    Barrail-Tran, A.
    Smirnova, M.
    Durrbach, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 68 - 68
  • [36] Generic Tacrolimus Based Immunosuppression among Renal Allograft Recipients in India
    Basu, G.
    Annapandian, V. M.
    Mathew, B. S.
    Saravanakumar, K.
    Kumaravel, S. G.
    Mohapatra, A.
    David, V. G.
    Alexander, S.
    Valson, A. T.
    Varughese, S.
    Fleming, D. H.
    Jacob, C. K.
    Tamilarasi, V
    John, G. T.
    TRANSPLANTATION, 2012, 94 (10) : 595 - 595
  • [37] Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients
    Beaudreuil, Severine
    Schermann, Jean Michel
    Verstuyft, Celine
    Barrail-Tran, Aurelie
    Smirnova, Maria
    Durrbach, Antoine
    Becquemont, Laurent
    CLINICAL TRANSPLANTATION, 2018, 32 (11)
  • [38] Immunosuppression switching from tacrolimus to sirolimus improves renal function in adult intestinal transplant recipients
    Hlaing, Htar Htar
    Butler, Andrew
    Amin, Irum
    Massey, Dunecan
    Russell, Neil
    Sharkey, Lisa
    Woodward, Jeremy
    Rutter, Charlotte
    TRANSPLANTATION, 2023, 107 (7S) : 28 - 28
  • [39] The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
    Flechner, S. M.
    Glyda, M.
    Cockfield, S.
    Grinyo, J.
    Legendre, Ch.
    Russ, G.
    Steinberg, S.
    Wissing, K. M.
    Tai, S. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) : 1633 - 1644
  • [40] Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients
    Lo, A
    Egidi, MF
    Gaber, LW
    Gaber, AO
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 105S - 108S
12345